Literature DB >> 18057558

Serotonin transporter gene polymorphism and BPSD in mild Alzheimer's disease.

Akinori Ueki1, Hideo Ueno, Noriko Sato, Hidetaka Shinjo, Yoshio Morita.   

Abstract

The purpose of the present study was to confirm an association of functional polymorphism within the serotonin transporter (5-HTT) gene with Alzheimer's disease (AD) and behavioral and psychological symptoms of dementia (BPSD) in mild AD. Apolipoprotein E (ApoE) gene polymorphism and 2 types of functional polymorphism in the 5-HTT gene, 5-HTT-linked polymorphic region (5-HTTLPR) and a 5-HTT variable number of tandem repeats sequence (5-HTTVNTR) were analyzed longitudinally in outpatients with mild AD to find out whether there was a relation between any such polymorphisms and the occurrence of BPSD. No significant differences in genotype distribution or allele frequencies were identified for 5-HTTLPR or 5-HTTVNTR between AD patients and age- and sex-matched non-demented controls regardless of ApoE epsilon4 allele. No significant differences were noted in 5-HTTLPR genotype or allele distributions between AD patients with or without BPSD. However, significant associations were observed between presence of 5-HTTVNTR allele 10 and BPSD or aggressiveness. This difference was independent of the presence of the ApoE epsilon4 allele. As a result, 5-HTT polymorphisms are unlikely to play any substantial role in susceptibility to AD. Conversely, 5-HTTVNTR influences the risk of developing BPSD or aggressiveness and genetic variations in the 5-HTT gene may be involved in the development of symptomatology for mild AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057558     DOI: 10.3233/jad-2007-12306

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  15 in total

1.  Citalopram for agitation in Alzheimer's disease: design and methods.

Authors:  Lea T Drye; Zahinoor Ismail; Anton P Porsteinsson; Paul B Rosenberg; Daniel Weintraub; Christopher Marano; Gregory Pelton; Constantine Frangakis; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; D P Devanand; Jerome Yesavage; Jacobo E Mintzer; Lon S Schneider; Bruce G Pollock; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012-02-01       Impact factor: 21.566

Review 2.  Genetics of psychosis of Alzheimer disease.

Authors:  Chintan Shah; Mary Ann A DeMichele-Sweet; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-01-12       Impact factor: 3.568

3.  Can dietary intervention help in management of problem behaviors in dementia?

Authors:  L Volicer
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

Review 4.  Serotonergic system, cognition, and BPSD in Alzheimer's disease.

Authors:  Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong
Journal:  Neurosci Lett       Date:  2019-04-01       Impact factor: 3.046

5.  Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.

Authors:  Alexandre Y Dombrovski; Benoit H Mulsant; Robert E Ferrell; Francis E Lotrich; Jules I Rosen; Meredith Wallace; Patricia R Houck; Sati Mazumdar; Bruce G Pollock
Journal:  Int Clin Psychopharmacol       Date:  2010-01       Impact factor: 1.659

Review 6.  Genetics of psychosis in Alzheimer's disease: a review.

Authors:  Mary Ann DeMichele-Sweet; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  VNTRseek-a computational tool to detect tandem repeat variants in high-throughput sequencing data.

Authors:  Yevgeniy Gelfand; Yozen Hernandez; Joshua Loving; Gary Benson
Journal:  Nucleic Acids Res       Date:  2014-07-23       Impact factor: 16.971

8.  Behavioural genetics of Alzheimer's disease: a comprehensive review.

Authors:  Marcin Flirski; Tomasz Sobow; Iwona Kloszewska
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

9.  NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.

Authors:  Yu-Jhen Huang; Chieh-Hsin Lin; Hsien-Yuan Lane; Guochuan E Tsai
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363

10.  Brain-derived Neurotrophic Factor Is Associated with Cognitive Impairment in Elderly Korean Individuals.

Authors:  Sang Jun Lee; Jun-Hyung Baek; Young-Hoon Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-12-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.